# AI for Onsite Cytology Evaluation in Endoscopic Ultrasound

> **NCT07228689** · — · RECRUITING · sponsor: **Orlando Health, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Gastrointestinal Neoplasm
- Mass Lesion

## Interventions

- **DIAGNOSTIC_TEST:** EUS-guided fine needle biopsy

## Key facts

- **NCT ID:** NCT07228689
- **Lead sponsor:** Orlando Health, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-12
- **Primary completion:** 2026-12
- **Final completion:** 2027-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07228689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07228689, "AI for Onsite Cytology Evaluation in Endoscopic Ultrasound". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07228689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*